CDSCO, DBT and ICMR Joint Guidelines for Evaluation of Nanopharmaceuticals in India

Guidelines for Evaluation <br>of Nanopharmaceuticals <br>in India<br>2019Department of Biotechnology<br>Ministry of Science &amp; Technology<br>Government of India<br>Central Drugs Standard Control Organization<br>Ministry of Health &amp; Family Welfare<br>Government of India<br>Indian Council for Medical Research<br>Ministry…

Continue ReadingCDSCO, DBT and ICMR Joint Guidelines for Evaluation of Nanopharmaceuticals in India

Salient features of the National Guidelines for Gene Therapy Product Development and Clinical Trails

Salient features of the &ldquo;National Guidelines for Ge ne Therapy Product <br>Development and Clinical Trials&rdquo; <br> <br>Inherited genetic diseases or &ldquo;rare diseases&rdquo; (RD) refer to medical conditions that <br>affect a…

Continue ReadingSalient features of the National Guidelines for Gene Therapy Product Development and Clinical Trails

ICMR- Good Clinical Laboratory Practices (GCLP)-2008

GUIDELINES FOR GOOD<br>CLINICAL LABORATORY<br>PRACTICES (GCLP)<br>Indian Council of Medical Research<br>New Delhi<br>2008<br>Published by:<br>Director-General<br>Indian Council of Medical ResearchNew Delhi-110029www.icmr.nic.in<br>September, 2008<br>© Copyright Indian Council of Medical Research<br>Production Controller :<br>J.N. Mathur, Press Manager, ICMR, New…

Continue ReadingICMR- Good Clinical Laboratory Practices (GCLP)-2008